151. p73-Governed miRNA Networks: Translating Bioinformatics Approaches to Therapeutic Solutions for Cancer Metastasis.
- Author
-
Logotheti S, Marquardt S, and Pützer BM
- Subjects
- Antagomirs pharmacology, Antagomirs therapeutic use, Antineoplastic Agents therapeutic use, Drug Resistance, Neoplasm drug effects, Drug Resistance, Neoplasm genetics, Gene Expression Regulation, Neoplastic drug effects, Gene Regulatory Networks drug effects, Humans, MicroRNAs antagonists & inhibitors, MicroRNAs metabolism, Neoplasms drug therapy, Neoplasms pathology, Protein Isoforms genetics, Protein Isoforms metabolism, Tumor Protein p73 genetics, Antineoplastic Agents pharmacology, Computational Biology methods, MicroRNAs genetics, Neoplasms genetics, Tumor Protein p73 metabolism
- Abstract
The transcription factor p73 synthesizes a large number of isoforms and presents high structural and functional homology with p53, a well-known tumor suppressor and a famous "Holy Grail" of anticancer targeting. p73 has attracted increasing attention mainly because (a) unlike p53, p73 is rarely mutated in cancer, (b) some p73 isoforms can inhibit all hallmarks of cancer, and (c) it has the ability to mimic oncosuppressive functions of p53, even in p53-mutated cells. These attributes render p73 and its downstream pathways appealing for therapeutic targeting, especially in mutant p53-driven cancers. p73 functions are, at least partly, mediated by microRNAs (miRNAs), which constitute nodal components of p73-governed networks. p73 not only regulates transcription of crucial miRNA genes, but is also predicted to affect miRNA populations in a transcription-independent manner by developing protein-protein interactions with components of the miRNA processing machinery. This combined effect of p73, both in miRNA transcription and maturation, appears to be isoform-dependent and can result in a systemic switch of cell miRNomes toward either an anti-oncogenic or oncogenic outcome. In this review, we combine literature search with bioinformatics approaches to reconstruct the p73-governed miRNA network and discuss how these crosstalks may be exploited to develop next-generation therapeutics.
- Published
- 2019
- Full Text
- View/download PDF